Three Major Biotech Stocks Decline Following Quarterly Earnings Updates

Three prominent biotechnology companies, including TG Therapeutics, Twist Biotech, and Krystal Biotech, recently experienced share price declines in financial markets.

The drop in market valuation coincided with the release of quarterly financial results and earnings reports across the sector.

Investors continue to monitor performance metrics and quarterly reports for these biotechnology firms as market conditions impact stock valuations.